M.D. Sass LLC’s GCI Liberty, Inc. Class A Common Stock (DE) GLIBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-235,886
Closed -$14.5M 56
2019
Q2
$14.5M Sell
235,886
-103,482
-30% -$6.14M 3.36% 13
2019
Q1
$18.9M Sell
339,368
-38,097
-10% -$1.93M 3.01% 19
2018
Q4
$15.5M Sell
377,465
-37,560
-9% -$1.74M 2.64% 23
2018
Q3
$21.2M Sell
415,025
-108,010
-21% -$5.19M 2.79% 22
2018
Q2
$23.6M Sell
523,035
-120,600
-19% -$5.56M 2.97% 18
2018
Q1
$34M Buy
+643,635
New +$33.7M 3.96% 9

Other funds holding GLIBA

M.D. Sass LLC's GLIBA Position: Q3 2019 in Review

M.D. Sass LLC sold out of GCI Liberty, Inc. Class A Common Stock (DE) (GLIBA) in Q3 2019, closing a stake of 235,886 shares — an estimated $14.5M sold.

M.D. Sass LLC first reported a position in GLIBA in Q1 2018 and held it in 6 quarters. The position peaked at $34M in Q1 2018. 280 funds tracked by Wall St. Rank hold GLIBA as of Q3 2019.

  • M.D. Sass LLC reported no remaining GCI Liberty, Inc. Class A Common Stock (DE) position as of Q3 2019 after selling out during the quarter.
  • M.D. Sass LLC sold 235,886 GCI Liberty, Inc. Class A Common Stock (DE) shares in Q3 2019, an estimated $14.5M.
  • M.D. Sass LLC first reported a position in GCI Liberty, Inc. Class A Common Stock (DE) in Q1 2018 and held it in 6 quarters.
  • M.D. Sass LLC's GCI Liberty, Inc. Class A Common Stock (DE) position peaked at $34M in Q1 2018.
  • 280 funds tracked by Wall St. Rank held GCI Liberty, Inc. Class A Common Stock (DE) as of Q3 2019.

Based on M.D. Sass LLC's 13F filing for Q3 2019, filed 14 Nov 2019.